News

At a recent congressional hearing on cannabis policy, Rep. James Comer (R-KY) made one thing clear: the FDA’s refusal to regulate CBD is hurting farmers, entrepreneurs, and consumers. Without federal clarity, the hemp industry has been forced to operate in uncertainty, leaving responsible businesses at risk while opening the door for bad actors.